Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Solid Tumor Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06625515
What this trial is testing

First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers

Who this might be right for
Advanced Solid TumorsBreast Cancer RecurrentColorectal Cancer Metastatic+3 more
Accent Therapeutics 17
Testing effectiveness (Phase 2)Study completedNCT05991349
What this trial is testing

IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07260058
What this trial is testing

Immune Cell Therapy for Advanced Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Liver Cancer (Locally Advanced or Metastatic)Colorectal Cancer (Locally Advanced or Metastatic)+2 more
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. 48
Early research (Phase 1)Ended earlyNCT04892043
What this trial is testing

Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 5
Testing effectiveness (Phase 2)Looking for participantsNCT06244992
What this trial is testing

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Pyrotech Therapeutics, Inc. 68
Testing effectiveness (Phase 2)Looking for participantsNCT05384626
What this trial is testing

Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 840
Early research (Phase 1)Study completedNCT02277717
What this trial is testing

First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients

Who this might be right for
Solid Tumors
Byondis B.V. 185
Testing effectiveness (Phase 2)Ended earlyNCT05326035
What this trial is testing

WJ05129 in Advanced Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Suzhou Junjing BioSciences Co., Ltd. 26
Early research (Phase 1)Study completedNCT01910545
What this trial is testing

Phase 1 Study of OTS167 in Patients With Solid Tumors

Who this might be right for
Solid TumorsMetastatic Tumors
OncoTherapy Science, Inc. 32
Early research (Phase 1)Looking for participantsNCT06979674
What this trial is testing

Study of ESG406 in Adults With Solid Tumors

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd 556
Early research (Phase 1)Study completedNCT00954642
What this trial is testing

MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT04799054
What this trial is testing

TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+4 more
Ascendis Pharma Oncology Division A/S 188
Early research (Phase 1)WithdrawnNCT05828277
What this trial is testing

Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Turning Point Therapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)Ended earlyNCT04547101
What this trial is testing

AK104 in Subjects With Locally Advanced Unresectable or Metastatic MSI-H/dMMR Solid Tumors

Who this might be right for
MSI-H/dMMR Solid Tumor
Akeso 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05544552
What this trial is testing

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

Who this might be right for
Locally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaSolid Tumor+11 more
Tyra Biosciences, Inc 310
Testing effectiveness (Phase 2)Study completedNCT02108964
What this trial is testing

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

Who this might be right for
Advanced Non-small Cell Lung Cancer
Novartis Pharmaceuticals 225
Testing effectiveness (Phase 2)Looking for participantsNCT07819136
What this trial is testing

REC-7735 in Participants With Solid Tumors

Who this might be right for
Solid Tumors
Recursion Pharmaceuticals Inc. 90
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Testing effectiveness (Phase 2)WithdrawnNCT03427320
What this trial is testing

Imaging of Advanced Tumours Using [131]I-IAZA

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
University of Alberta
Next Page